Posts Tagged Centers for Disease Control and Prevention
by: Dr. Mercola
August 2, 2012
There’s no shortage of stories detailing conflicts of interest—so many in fact that you may be getting sick and tired of hearing of them. However, this is a truly important issue that must be tackled, and one of the ways of doing that is by exposing it to the harsh light of day. As long as people remain unaware, or turn a blind eye, it will continue unabated.
The price we pay for not paying attention is the loss of health, as the information disseminated by grossly compromised health agencies is skewed in favor of various industries, with Big Pharma leading the pack as one of the most powerful political and governmental influences.
Here, I will review two important revolving-door cases, and while neither is recent news, many of you may still be unaware of them.
Former CDC Director Now President of Merck’s Vaccine Unit
In the summer of 2011, Merck president Julie Gerberding said in a news interview1 that she’s “very bullish on vaccines,” as she recounted the various ways she helps Merck sell its products. What she didn’t divulge was her motivation for leaving her job as director of the Centers for Disease Control and Prevention (CDC)—an agency charged with overseeing vaccines and drug companies—and join Merck in the first place, back in January 2010.
If you don’t see the enormity of the influence her former high-level ties to the CDC can have, just consider the fact that Merck makes 14 of the 17 pediatric vaccines recommended by the CDC, and 9 of the 10 recommended for adults, and while vaccine safety advocates are trying to rein in the number of vaccines given to babies, safety concerns keep falling on deaf ears. The vaccine industry is booming, and it’s become quite clear that profit potential is the driving factor behind it.
One of the reasons for this is because vaccine patents do not expire like drugs do, so each vaccine adopted for widespread use has the potential to make enormous, continuous profits for decades to come. Vaccine makers also enjoy a high degree of immunity against lawsuits—and in the case of pandemic vaccines, absolute immunity—so the financial liability when something goes wrong is very low, compared to drugs.
Gerberding has a Long History of Disregard for Vaccine Safety
Joining a parade of other high-ranking government officials who pass through the revolving doors between government and Big Pharma, Gerberding left a trail of controversy behind her when she left the CDC. While a 2009 article by the Institute for Southern Studies lists a number of them2, I believe they left out the most important ones, namely her misinformation campaign about the pandemic swine flu vaccine, as well as her naive stance on vaccine safety issues in general.
The CDC disseminated extremely exaggerated data on the 2009 H1N1 “pandemic” and urged almost everyone in the U.S. to take the new, untested vaccines. When questions arose, they blocked CBS’s requests for samples of the swine flu cases and added obstacles to getting information. Despite the many dangers that have since been linked to the hastily developed vaccine—including the confirmed link to narcolepsy—the H1N1 vaccine is now part and parcel of the “regular” seasonal flu vaccine, although most people are completely unaware of this fact. And the CDC is now, for the first time ever, urging the seasonal flu vaccine on everyone in the country, from six months’ of age until death.
Even more disturbing, the CDC withheld data on miscarriages from the H1N1 vaccines under Gerberding’s lead, while insisting that pregnant women be put first in line to receive it. This was a dramatic reversal of its own recommendations. More than 3,500 post-vaccination miscarriages may have simply been ignored by the CDC.
One of Merck’s potentially most dangerous vaccines right now is Gardasil; a vaccine that so far has been linked to thousands of adverse events and at least 49 unexplained deaths. It’s a situation that the FDA and CDC have repeatedly denied, even as the adverse reports mount.
Gerberding’s 2004 report to Congress, ‘Prevention of Genital Human Papillomavirus Infection‘3 likely played a significant role in getting the controversial vaccine approved in the first place. Needless to say, the approval of this questionable vaccine guaranteed her future employer billions of dollars-worth of profits. Gerberding has also been a staunch defender of thimerosal, the mercury-based preservative used in many vaccines, and has consistently denied any links between vaccines and autism.
All in all, Gerberding has repeatedly demonstrated that safety is nowhere on her list of priorities or concerns when it comes to vaccines. It’s easy to see why Merck would want her to head up their vaccine unit. For the rest of us, however, her blatant disregard for provenvaccine safety is bad news indeed.
Tuesday, July 17, 2012
By: Ethan A. Huff
[NaturalNews] Growing awareness about the prolific presence of the hormone disruptor bisphenol A (BPA) in plastics, receipt paper, money, and various other consumer products and materials has led to the widespread removal of this highly toxic chemical from many products in recent years. But bisphenol S (BPS), the chemical now being used in place of BPA in many “BPA-free” products, may be just as harmful — if not more harmful — than BPA.
A new study published in the ACS journal Environmental Science & Technology is the first to analyze the presence of BPS in consumer products, and particularly in both thermal and recycled paper products. According to Kurunthachalam Kannan and colleagues who conducted the study, BPS is similar to BPA in that it mimics estrogen, and can cause severe endocrine disruption as a result of repeated exposure.
For their study, which was funded in part by the U.S. Centers for Disease Control and Prevention (CDC), the National Natural Science Foundation of China, and the Department of Science and Technology of Shandong Province, Kannan and the team tested 16 different types of paper and paper products, including thermal receipt paper, paper currencies, flyers, magazines, newspapers, food contact papers, airplane luggage tags, printing paper, paper towels, and toilet papers.
They found that every single tested sample of thermal receipt paper, which is used by most retailers nowadays to print purchase receipts, tested positive for BPS at concentrations ranging from 0.0000138 milligrams per gram (mg/g) to 22.0 mg/g. This is roughly the same range level that has been observed in thermal receipt paper for BPA in earlier studies.
BPS is up to 19 times more absorbable in the skin than BPA
The research team also found that 87 percent of currency bill samples, which were collected from 21 different countries, contained BPS in varying levels. BPS was also observed in 14 of the other paper products sampled as well, including in 52 percent of recycled paper samples tested, which indicates that this largely unknown chemical is quietly hiding in all sorts of paper products that millions of people are exposed to every single day.
Perhaps the most disturbing finding about BPS; however, is the fact that BPS absorbs into the skin at much higher rates than BPA. According to the study, BPS is capable of absorbing at a rate up to 1900 percent higher than BPA, which makes it potentially much more harmful than BPA at altering hormone levels.
According to a 2005 study out of Japan, BPS is only slightly less potent than BPA at mimicking the female hormone estrogen in the body. However, other studies have shown that BPS is far less biodegradable than BPA, and is actually the most persistent bisphenol compound among eight of the most common bisphenol compounds tested. (http://www.environmentalhealthnews.org)
Sources for this article include:
by: Dr. Mercola
July 7, 2012
While the fear of a mutated virus turning into a pandemic is flouted virtually every year to some degree, perhaps a greater concern is the potential for an engineered bioweapon somehow escaping the confines of our top level bioterror labs—a possibility that seems increasingly credible, when you consider the astounding safety “snafus” that occur at these labs from time to time.
The recent incident at the bioterror germ lab at the Centers for Disease Control and Prevention (CDC) in Atlanta is just the latest scare, and it highlights the fact that seemingly unbelievable errors can and do occur, despite all guarantees to the contrary.
Bio Lab Safety Questioned
“A $214 million bioterror germ lab at the Centers for Disease Control and Prevention in Atlanta has had repeated problems with airflow systems designed to help prevent the release of infectious agents, government documents and internal emails show.
While the agency says no one has been infected, a biosafety expert says the problems appear to be major violations of laboratory operating standards.
The area of the building with problems involves Biosafety Level 3 labs that can be used for experiments involving anthrax, dangerous strains of influenza, the SARS coronavirus, monkeypox and other microbes that have the potential to be used as bioweapons.” [Emphasis mine]
Apparently, air from a research lab in one of the Biosafety Level 3 buildings was being vented into a so-called “clean” area, where visitors are not required to wear protective gear, rather than being filtered and re-circulated. While it’s being reported as an isolated incident, CDC engineers appear to have raised questions about the design of the vented air flow as early as two years ago.
“According to the minutes, CDC safety manager William Howard said: “Bottom line is we can’t continue to operate the building the way it is … if (a bioterror lab inspector) finds out air is moving this direction they will shut this place down.”
The CDC refused to grant interviews or answer any questions submitted in writing about the problems inside the high-containment labs and animal-holding area of the agency’s 11-story Emerging Infectious Diseases Laboratory, also known as CDC Building 18,” The Federal Times reports.
…The records show that other CDC staff have expressed safety concerns. The CDC “will do anything… to hide the fact that we have serious problems with the airflow and containment in this whole building” wrote CDC animal resources biologist Kismet Scarborough in an April 9 e-mail to several agency officials, including CDC Director Thomas Frieden. Scarborough’s CDC voice-mail greeting describes her position as a high-containment lab manager for the agency’s Animal Resources Branch.”
Vaccine Lab Researcher Dead from Lethal Pathogen
According to a recent CNN reportii, a congressional investigation will be launched to investigate the safety breach at the Atlanta facility. But beware that despite assurances that chances of contaminant release is virtually non-existent, it certainly can occur, and you could just as easily chalk it up to pure luck that no lethal pathogens escaped at the CDC lab.
As you may recall, back in April, a reportedly well-trained lab researcher at the Northern California Institute for Research died shortly after being infected with the Neisseria meningitides bacteriaiii. He was working on a vaccine against the pathogen, and according to the site chief was following required precautions for working with the deadly pathogens.
While that sounds all well and good, it actually makes the situation all the MORE dire, as it obviously means there must be serious flaws in the system if he actually followed all precautions and still got infected.
The young man died a mere 17 hours after initially falling ill.
I mention these incidents because as the vaccine industry is getting more aggressive in their promotion of fast-tracked vaccines, incidents such as these, and many others, really highlight the dangers inherent in the system overall, and why you cannot blindly believe the official story that drugs and vaccines are somehow created under pristine conditions and that nothing can go wrong. Because they most certainly do…